MIRA Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Other
MIRA Pharmaceuticals, Inc. (MIRA) reported Adjustments to Additional Paid in Capital, Other of $148.70 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2025-11-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2025-11-13
- MIRA Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2024-06-30 was $148.70K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month |
|---|---|
| 2024-06-30 | $148.70K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |